NTEK-B.ST
Novotek AB [NTEK-B.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NTEK-B.ST Stock Summary
Top 10 Correlated Stocks
NTEK-B.ST
In the News
NTEK-B.ST Financial details
Company Rating
Buy
Market Cap
669.71M
Income
24.79M
Revenue
390.3M
Book val./share
19.06
Cash/share
9.63
Dividend
1.5
Dividend %
3%
Employees
186
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
23.73
Forward P/E
-
PEG
-11.9
P/S
1.42
P/B
2.75
P/C
6.46
P/FCF
13.58
Quick Ratio
1.31
Current Ratio
1.47
Debt / Equity
0.08
LT Debt / Equity
0.03
-
-
EPS (TTM)
2.35
EPS next Y
-
EPS next Q
-
EPS this Y
5.46%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
4.16%
Revenue last 5Y
10.59%
Revenue Q/Q
46.32%
EPS Q/Q
613.64%
-
-
-
-
SMA20
-3.08%
SMA50
23.53%
SMA100
46.51%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
12%
ROC
0.14%
Gross Margin
20%
Oper. Margin
9%
Profit Margin
6%
Payout
71%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
40.0-68.2
52W High
-8.53%
52W Low
+55.5%
RSI
49
Rel Volume
0.14
Avg Volume
7.84K
Volume
1.1K
Perf Week
-4.01%
Perf Month
1.14%
Perf Quarter
26.94%
Perf Half Y
31.36%
-
-
-
-
Beta
1.001
-
-
Volatility
0.83%, 1.3%
Prev Close
-0.32%
Price
62.2
Change
1.3%
NTEK-B.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 28.67 | 30.1 | 36.86 | 40.82 | 47.42 | |
| Net income per share | 2.52 | 2.68 | 3.75 | 2.93 | 3.09 | |
| Operating cash flow per share | 2.98 | 4.68 | 4.19 | 4.65 | 3.94 | |
| Free cash flow per share | 2.8 | 4.48 | 3.87 | 4.15 | 3.49 | |
| Cash per share | 6.23 | 9.39 | 10.3 | 8.85 | 9.63 | |
| Book value per share | 11.28 | 13.29 | 15.4 | 17.57 | 19.06 | |
| Tangible book value per share | 5.37 | 6.6 | 8.24 | 3.63 | 5.38 | |
| Share holders equity per share | 11.28 | 13.29 | 15.4 | 17.57 | 19.06 | |
| Interest debt per share | 1.37 | 1.41 | 1.41 | 2.01 | 1.63 | |
| Market cap | 392.2M | 468.52M | 792.88M | 477M | 519.4M | |
| Enterprise value | 337.66M | 383.12M | 695.8M | 402.45M | 433.45M | |
| P/E ratio | 14.69 | 16.47 | 19.94 | 15.37 | 15.84 | |
| Price to sales ratio | 1.29 | 1.47 | 2.03 | 1.1 | 1.03 | |
| POCF ratio | 12.41 | 9.45 | 17.84 | 9.68 | 12.43 | |
| PFCF ratio | 13.23 | 9.86 | 19.33 | 10.83 | 14.04 | |
| P/B Ratio | 3.28 | 3.32 | 4.86 | 2.56 | 2.57 | |
| PTB ratio | 3.28 | 3.32 | 4.86 | 2.56 | 2.57 | |
| EV to sales | 1.11 | 1.2 | 1.78 | 0.93 | 0.86 | |
| Enterprise value over EBITDA | 7.53 | 8.21 | 11.64 | 7.42 | 6.72 | |
| EV to operating cash flow | 10.69 | 7.73 | 15.65 | 8.17 | 10.37 | |
| EV to free cash flow | 11.39 | 8.07 | 16.97 | 9.14 | 11.71 | |
| Earnings yield | 0.07 | 0.06 | 0.05 | 0.07 | 0.06 | |
| Free cash flow yield | 0.08 | 0.1 | 0.05 | 0.09 | 0.07 | |
| Debt to equity | 0.12 | 0.1 | 0.09 | 0.11 | 0.08 | |
| Debt to assets | 0.06 | 0.05 | 0.04 | 0.05 | 0.04 | |
| Net debt to EBITDA | -1.22 | -1.83 | -1.62 | -1.38 | -1.33 | |
| Current ratio | 1.57 | 1.7 | 1.69 | 1.35 | 1.37 | |
| Interest coverage | 60.57 | 42.35 | 75.43 | 29.15 | 41.12 | |
| Income quality | 0.91 | 1.34 | 0.9 | 1.17 | 1.27 | |
| Dividend Yield | 0.03 | 0 | 0.03 | 0.03 | 0.03 | |
| Payout ratio | 0.5 | 0 | 0.6 | 0.51 | 0.48 | |
| Sales general and administrative to revenue | 0.06 | 0.06 | 0.06 | 0.06 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.27 | 0.26 | 0.24 | 0.36 | 0.34 | |
| Capex to operating cash flow | -0.06 | -0.04 | -0.08 | -0.11 | -0.11 | |
| Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Capex to depreciation | -0.2 | -0.22 | -0.36 | -0.44 | -0.29 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 25.29 | 28.33 | 36.06 | 34.02 | 36.42 | |
| ROIC | 0.18 | 0.17 | 0.2 | 0.15 | 0.15 | |
| Return on tangible assets | 0.15 | 0.14 | 0.16 | 0.12 | 0.11 | |
| Graham Net | 1.24 | 2.73 | 3.36 | -2.45 | -2.21 | |
| Working capital | 56.05M | 77.17M | 90.22M | 62.4M | 71.5M | |
| Tangible asset value | 56.97M | 69.95M | 87.36M | 38.52M | 57.07M | |
| Net current asset value | 38.2M | 52.31M | 66.65M | 12.32M | 30.7M | |
| Invested capital | 0.12 | 0.1 | 0.09 | 0.11 | 0.08 | |
| Average receivables | 42.37M | 85.23M | 95.86M | 123.94M | 142.83M | |
| Average payables | 31.55M | 28.83M | 34.94M | 44.93M | 52.4M | |
| Average inventory | 1.24M | 1.29M | 1.86M | 1.79M | 1.04M | |
| Days sales outstanding | 101.78 | 98.05 | 99.04 | 119.65 | 104.41 | |
| Days payables outstanding | 38.79 | 45.59 | 44.81 | 53.77 | 42.52 | |
| Days of inventory on hand | 1.61 | 2.16 | 2.6 | 1.42 | 0.56 | |
| Receivables turnover | 3.59 | 3.72 | 3.69 | 3.05 | 3.5 | |
| Payables turnover | 9.41 | 8.01 | 8.14 | 6.79 | 8.58 | |
| Inventory turnover | 227.24 | 168.81 | 140.23 | 256.68 | 650 | |
| ROE | 0.22 | 0.2 | 0.24 | 0.17 | 0.16 | |
| Capex per share | -0.18 | -0.2 | -0.33 | -0.49 | -0.45 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 13.56 | 0.31 | 11.88 | 10 | 14.63 | |
| Net income per share | 1.33 | -0.09 | 0.65 | 0.22 | 1.57 | |
| Operating cash flow per share | 1.96 | 1.92 | 0.01 | 0.58 | 1.44 | |
| Free cash flow per share | 1.62 | 1.79 | -0.12 | 0.46 | 1.36 | |
| Cash per share | 8.85 | 10.25 | 8.79 | 8.87 | 9.63 | |
| Book value per share | 17.57 | 18.33 | 18.4 | 18.21 | 19.06 | |
| Tangible book value per share | 3.63 | 4.28 | 3.63 | 3.89 | 5.38 | |
| Share holders equity per share | 17.57 | 18.33 | 18.4 | 18.21 | 19.06 | |
| Interest debt per share | 1.9 | 0.05 | 0.08 | 0.02 | 1.49 | |
| Market cap | 477M | 588.3M | 538.48M | 514.1M | 519.4M | |
| Enterprise value | 402.45M | 479.6M | 445.28M | 420.1M | 433.45M | |
| P/E ratio | 8.44 | -147.08 | 19.51 | 55.88 | 7.83 | |
| Price to sales ratio | 3.32 | 178.27 | 4.28 | 4.85 | 3.35 | |
| POCF ratio | 22.97 | 28.98 | 5.38K | 84.28 | 33.95 | |
| PFCF ratio | 27.83 | 30.96 | -414.22 | 104.92 | 36.07 | |
| P/B Ratio | 2.56 | 3.03 | 2.76 | 2.66 | 2.57 | |
| PTB ratio | 2.56 | 3.03 | 2.76 | 2.66 | 2.57 | |
| EV to sales | 2.8 | 145.33 | 3.54 | 3.96 | 2.79 | |
| Enterprise value over EBITDA | 16.62 | -685.14 | 31.81 | 47.74 | 15 | |
| EV to operating cash flow | 19.38 | 23.63 | 4.45K | 68.87 | 28.33 | |
| EV to free cash flow | 23.48 | 25.24 | -342.52 | 85.73 | 30.1 | |
| Earnings yield | 0.03 | 0 | 0.01 | 0 | 0.03 | |
| Free cash flow yield | 0.04 | 0.03 | 0 | 0.01 | 0.03 | |
| Debt to equity | 0.11 | 0 | 0 | 0 | 0.08 | |
| Debt to assets | 0.05 | 0 | 0 | 0 | 0.04 | |
| Net debt to EBITDA | -3.08 | 155.29 | -6.66 | -10.68 | -2.97 | |
| Current ratio | 1.35 | 1.49 | 1.47 | 1.47 | 1.37 | |
| Interest coverage | 59.27 | -1.6 | 12.25 | 21.5 | -72.06 | |
| Income quality | 0.99 | 2.28 | 0.01 | 1.45 | 0.92 | |
| Dividend Yield | 0 | 0 | 0.03 | 0 | 0 | |
| Payout ratio | 0 | 0 | 2.3 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0.45 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.01 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.36 | 0.38 | 0.41 | 0.42 | 0.34 | |
| Capex to operating cash flow | -0.17 | -0.06 | -14 | -0.2 | -0.06 | |
| Capex to revenue | -0.03 | -0.39 | -0.01 | -0.01 | -0.01 | |
| Capex to depreciation | -0.86 | -0.33 | -0.34 | -0.27 | -0.2 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 22.96 | 6.24 | 16.41 | 9.43 | 25.91 | |
| ROIC | 0.07 | -0.01 | 0.04 | 0.01 | 0.08 | |
| Return on tangible assets | 0.05 | 0 | 0.03 | 0.01 | 0.06 | |
| Graham Net | -2.45 | -2.14 | -3.27 | -1.84 | -2.21 | |
| Working capital | 62.4M | 71.6M | 66.1M | 62.1M | 71.5M | |
| Tangible asset value | 38.52M | 45.4M | 38.5M | 41.2M | 57.07M | |
| Net current asset value | 12.32M | 21.5M | 15.3M | 21.5M | 30.7M | |
| Invested capital | 0.11 | 0 | 0 | 0 | 0.08 | |
| Average receivables | 100.88M | 113.68M | 85.65M | 81.4M | 110.4M | |
| Average payables | 41.5M | 44.9M | 35.4M | 32.55M | 42.65M | |
| Average inventory | 2.39M | 1.24M | 1000K | 800K | 700K | |
| Days sales outstanding | 88.82 | 2.33K | 61.33 | 65.38 | 83.44 | |
| Days payables outstanding | 41.87 | 1.32K | 29.23 | 32.85 | 36.52 | |
| Days of inventory on hand | 1.11 | 38.08 | 0.8 | 0.71 | 0.48 | |
| Receivables turnover | 1.01 | 0.04 | 1.47 | 1.38 | 1.08 | |
| Payables turnover | 2.15 | 0.07 | 3.08 | 2.74 | 2.46 | |
| Inventory turnover | 81.28 | 2.36 | 112.22 | 126.43 | 186.57 | |
| ROE | 0.08 | -0.01 | 0.04 | 0.01 | 0.08 | |
| Capex per share | -0.34 | -0.12 | -0.13 | -0.11 | -0.08 |
NTEK-B.ST Frequently Asked Questions
What is Novotek AB stock symbol ?
Novotek AB is a SE stock and trading under the symbol NTEK-B.ST
What is Novotek AB stock quote today ?
Novotek AB stock price is $62.2 today.
Is Novotek AB stock public?
Yes, Novotek AB is a publicly traded company.
Company Profile
- Volume Average 7.84K
- Market Capitalization 669.71M
- Employee 186
- CEO Mr. Tobias Antius
- Headquarters Malmö,SE
- IPO Date 2000-01-03
-
Website
https://www.novotek.com 
Novotek AB delivers solutions in the industrial IT and automation areas. The company designs, implements, deploys, and maintains its customers' systems for production management and control. It operates in Nordic, Benelux countries, Switzerland, the United Kingdom, and Ireland. The company was incorporated in 1955 and is headquartered in Malmö, Sweden.
